Showing results (1-10 of 419) with videos related to
Sort By:
Pageof 42
Current Atherosclerosis Reports|March 15, 2016
Approach to Statin Use in 2016: an UpdateP Elliott Miller, Seth S MartinClinical Therapeutics|February 29, 2016
Pitavastatin 4 mg Provides Significantly Greater Reduction in Remnant Lipoprotein Cholesterol Compared With Pravastatin 40 mg: Results from the Short-term Phase IV PREVAIL US Trial in Patients With Primary Hyperlipidemia or Mixed DyslipidemiaP Elliott Miller, Seth S Martin, Parag H Joshi, et al.AIDS (London, England)|January 26, 2017
Greater remnant lipoprotein cholesterol reduction with pitavastatin compared with pravastatin in HIV-infected patientsParag H Joshi, P Elliott Miller, Seth S Martin, et al.Journal of Clinical Lipidology|September 10, 2015
Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17)P Elliott Miller, Seth S Martin, Peter P Toth, et al.Trends in Cardiovascular Medicine|November 11, 2019
How useful is the smartwatch ECG?Nino Isakadze, Seth S MartinCritical Care Medicine|September 1, 2017
Advanced Percutaneous Mechanical Circulatory Support Devices for Cardiogenic ShockP Elliott Miller, Michael A Solomon, Dorothea McAreaveyClinica Chimica Acta; International Journal of Clinical Chemistry|March 25, 2020
More accurate LDL-C calculation: Externally validated, guideline endorsedAdam J Brownstein, Seth S MartinDrug Safety|May 21, 2015
PCSK9 inhibitors and neurocognitive adverse events: exploring the FDA directive and a proposal for N-of-1 trialsKristopher J Swiger, Seth S MartinAmerican Heart Journal|January 16, 2023
Trends in outcomes and resource utilization for acute myocardial infarction admissions during the COVID-19 pandemicFouad Chouairi, Bret Pinsker, Marat Fudim, et al.American Heart Journal|May 8, 2023
Effects of COVID-19 on heart failure admissionsFouad Chouairi, Bret Pinsker, P Elliott Miller, et al.Pageof 42